FDA Approves Ngenla (somatrogon-ghla) for Pediatric Growth Hormone Deficiency
FDA approves once-weekly growth hormone drug Ngenla for children
FDA approved Ngenla (somatrogon-ghla) for treatment of pediatric patients aged 3 years and older with growth failure due to inadequate secre…
The FDA approved Ngenla (somatrogon-ghla), a once-weekly injection for children 3 and older with growth failure due to low growth hormone. I…
Meta-analysis indicates increased BMI SD scores with long-acting growth hormone versus daily rhGH in children
New Growth Hormone Treatment Tied to Weight Gain in Kids
This meta-analysis evaluated body mass index (BMI) SD scores in 585 children with growth hormone deficiency treated with long-acting growth …
This treatment could change how kids grow — but it might also affect their weight.